Paul Ogongo, PhD

Title(s)Postdoctoral Scholar, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave, #605A
San Francisco CA 94110
Phone628-206-8101
ORCID ORCID Icon0000-0002-0093-5768 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Nairobi, KenyaBSc 09/2007Zoology
    Jomo Kenyatta University of Agriculture and Technology, KenyaMSc11/2014Molecular Medicine
    University of KwaZulu Natal, South AfricaPhD07/2019Medical Microbiology
    Collapse Awards and Honors
    University of California San Francisco2023  - 2025TB RAMP Scholar
    Helen Hay Whitney Foundation2021  - 2024Postdoctoral Fellow
    Bill and Melinda Gates Foundation2019  - 2019Rising Star

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL-17 against M. tuberculosis antigen. Frontiers in Immunology. 2024 Apr 18; 15:1378040. Ogongo OP, Tran TA, Marzan MF, Gingrich GD, Krone KM, Aweeka AF, Arlehamn AC, Martin MJ, Deeks DS, Hunt HP, Ernst EJ. .
      View in: Publisher Site   Mentions:
    2. Rare Variable M. tuberculosis Antigens induce predominant Th17 responses in human infection. bioRxiv. 2024 Mar 06. Ogongo P, Wassie L, Tran A, Columbus D, Sharling L, Ouma G, Ouma SG, Bobosha K, Lindestam Arlehamn CS, Gandhi NR, Auld SC, Rengarajan J, Day CL, Altman JD, Blumberg HM, Ernst JD, TBRU ASTRa Study Group. PMID: 38496518; PMCID: PMC10942433.
      View in: PubMed   Mentions:
    3. High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL17 against M. tuberculosis antigen. bioRxiv. 2024 Mar 06. Ogongo P, Tran A, Marzan F, Gingrich D, Krone M, Aweeka F, Lindestam Arlehamn CS, Martin JN, Deeks SG, Hunt PW, Ernst JD. PMID: 36711855; PMCID: PMC9881994.
      View in: PubMed   Mentions:
    4. Recognition and control of Mycobacterium tuberculosis-infected cells: from basics to the clinic: a NIAID/WGNV workshop report 2023. 2023. Carly C Young, Mbali N. Mkhonza, Paul Ogongo. .
    5. Recognition and control of Mycobacterium tuberculosis-infected cells: from basics to the clinic: a NIAID/WGNV workshop report 2023. . 2023 Nov 15; 1:1303505. Young YC, Mkhonza MM, Ogongo OP. .
      View in: Publisher Site   Mentions:
    6. B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and putative functional roles. 2023. Robert Krause; Paul Ogongo; Liku Tezera; Mohamed Ahmed; Ian Mbano; Mark Chambers; Abigail Ngoepe; Magalli Magnoumba; Daniel Muema; Farina Karim;Khadija Khan; Kapongo Lumamba; Kievershen Nargan; Rajhmun Madansein; Adrie JC Steyn; Alex K. Shalek; Paul T Elkington; Alasdair Leslie . .
    7. Finding antigens for TB vaccines: the good, the bad and the useless. Nat Med. 2023 01; 29(1):35-36. Ogongo P, Ernst JD. PMID: 36604539; PMCID: PMC9877171.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Do vaginal microbicides reduce the risk of HIV acquisition in women? Pan Afr Med J. 2022; 43:96. Obiero JA, Ogongo P, Mwethera PG, Wiysonge CS. PMID: 36660088; PMCID: PMC9816879.
      View in: PubMed   Mentions:    Fields:    
    9. The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game. Front Immunol. 2022; 13:846108. Ogongo P, Nyakundi RK, Chege GK, Ochola L. PMID: 35592327; PMCID: PMC9112563.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    10. Acquired Clinical Immunity to Malaria in Nonhuman Primates Coinfected with Schistosoma and Plasmodium Parasites. Infect Immun. 2022 02 17; 90(2):e0046421. Nyakundi RK, Hau J, Ogongo P, Nyamongo O, Jeneby M, Akinyi M, Mulei I, Nyundo F, Farah I, Malhotra I, Ozwara H, King CL, Kariuki T. PMID: 34871040; PMCID: PMC8853685.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    11. Repeated Plasmodium falciparum infection in humans drives the clonal expansion of an adaptive γδ T cell repertoire. Sci Transl Med. 2021 12; 13(622):eabe7430. von Borstel A, Chevour P, Arsovski D, Krol JMM, Howson LJ, Berry AA, Day CL, Ogongo P, Ernst JD, Nomicos EYH, Boddey JA, Giles EM, Rossjohn J, Traore B, Lyke KE, Williamson KC, Crompton PD, Davey MS. PMID: 34851691; PMCID: PMC9291638.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    12. A Framework to Identify Antigen-Expanded T Cell Receptor Clusters Within Complex Repertoires. Front Immunol. 2021; 12:735584. Ceglia V, Kelley EJ, Boyle AS, Zurawski S, Mead HL, Harms CE, Blanck JP, Flamar AL, Kirschman JH, Ogongo P, Ernst JD, Levy Y, Zurawski G, Altin JA. PMID: 34917073; PMCID: PMC8670329.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    13. Performance evaluation of lateral flow assays for COVID-19 serology. Clinics in Laboratory Medicine. 2021 Nov 3. Ochola OL, Ogongo OP, Mungai MS, Gitaka GJ, Suliman SS. .
      View in: Publisher Site   Mentions:
    14. Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung. J Clin Invest. 2021 05 17; 131(10). Ogongo P, Tezera LB, Ardain A, Nhamoyebonde S, Ramsuran D, Singh A, Ng'oepe A, Karim F, Naidoo T, Khan K, Dullabh KJ, Fehlings M, Lee BH, Nardin A, Lindestam Arlehamn CS, Sette A, Behar SM, Steyn AJ, Madansein R, Kløverpris HN, Elkington PT, Leslie A. PMID: 33848273; PMCID: PMC8121523.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCellsCTClinical Trials
    15. Topical microbicides for preventing sexually transmitted infections. Cochrane Database Syst Rev. 2021 03 13; 3:CD007961. Obiero J, Ogongo P, Mwethera PG, Wiysonge CS. PMID: 33719075; PMCID: PMC8092571.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    16. Unbiased Profiling Reveals Compartmentalization of Unconventional T-Cells Within the Intestinal Mucosa Irrespective of HIV Infection. Front Immunol. 2020; 11:579743. Magnoumba M, Singh A, Ogongo P, Roider J, Asowata O, Fehlings M, Karim F, Ndung'u T, Anderson F, Leslie A, Kløverpris H. PMID: 33117384; PMCID: PMC7561384.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    17. Single cell transcriptomics of the T cell response to Mycobacterium Tuberculosis reveals phenotypic diversity within and between infected individuals. The Journal of Immunology. 2020 May 1; 204(1_Supplement):225.21-225.21. Kirschman KJ, Ogongo OP, Ernst EJ, Altin AJ. .
      View in: Publisher Site   Mentions:
    18. Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α. Elife. 2020 02 24; 9. Tezera LB, Bielecka MK, Ogongo P, Walker NF, Ellis M, Garay-Baquero DJ, Thomas K, Reichmann MT, Johnston DA, Wilkinson KA, Ahmed M, Jogai S, Jayasinghe SN, Wilkinson RJ, Mansour S, Thomas GJ, Ottensmeier CH, Leslie A, Elkington PT. PMID: 32091388; PMCID: PMC7058383.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    19. Differential skewing of donor-unrestricted and γδ T cell repertoires in tuberculosis-infected human lungs. J Clin Invest. 2020 01 02; 130(1):214-230. Ogongo P, Steyn AJ, Karim F, Dullabh KJ, Awala I, Madansein R, Leslie A, Behar SM. PMID: 31763997; PMCID: PMC6934215.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    20. Publisher Correction: Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019 Aug; 572(7768):E10. Ardain A, Domingo-Gonzalez R, Das S, Kazer SW, Howard NC, Singh A, Ahmed M, Nhamoyebonde S, Rangel-Moreno J, Ogongo P, Lu L, Ramsuran D, de la Luz Garcia-Hernandez M, Ulland TK, Darby M, Park E, Karim F, Melocchi L, Madansein R, Dullabh KJ, Dunlap M, Marin-Agudelo N, Ebihara T, Ndung'u T, Kaushal D, Pym AS, Kolls JK, Steyn A, Zúñiga J, Horsnell W, Yokoyama WM, Shalek AK, Kløverpris HN, Colonna M, Leslie A, Khader SA. PMID: 31337923.
      View in: PubMed   Mentions:    Fields:    
    21. Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children. Front Immunol. 2019; 10:1497. Roider J, Porterfield JZ, Ogongo P, Muenchhoff M, Adland E, Groll A, Morris L, Moore PL, Ndung'u T, Kløverpris H, Goulder PJR, Leslie A. PMID: 31333650; PMCID: PMC6615198.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    22. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019 06; 570(7762):528-532. Ardain A, Domingo-Gonzalez R, Das S, Kazer SW, Howard NC, Singh A, Ahmed M, Nhamoyebonde S, Rangel-Moreno J, Ogongo P, Lu L, Ramsuran D, de la Luz Garcia-Hernandez M, K Ulland T, Darby M, Park E, Karim F, Melocchi L, Madansein R, Dullabh KJ, Dunlap M, Marin-Agudelo N, Ebihara T, Ndung'u T, Kaushal D, Pym AS, Kolls JK, Steyn A, Zúñiga J, Horsnell W, Yokoyama WM, Shalek AK, Kløverpris HN, Colonna M, Leslie A, Khader SA. PMID: 31168092; PMCID: PMC6626542.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansAnimalsCells
    23. Lung Tissue Resident Memory T-Cells in the Immune Response to Mycobacterium tuberculosis. Front Immunol. 2019; 10:992. Ogongo P, Porterfield JZ, Leslie A. PMID: 31130965; PMCID: PMC6510113.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    24. Major TCR Repertoire Perturbation by Immunodominant HLA-B*44:03-Restricted CMV-Specific T Cells. Front Immunol. 2018; 9:2539. Attaf M, Malik A, Severinsen MC, Roider J, Ogongo P, Buus S, Ndung'u T, Leslie A, Kløverpris HN, Matthews PC, Sewell AK, Goulder P. PMID: 30487790; PMCID: PMC6246681.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    25. Nifuratel‐Nystatin combination for the treatment of mixed infections of bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis. Cochrane Database Systematic Reviews. 2018; (4). Jael Obrero, Stephen Rulisa, Paul Ogongo and Charles S Wiysonge. . View Publication.
    26. Diagnosis of schistosomiasis mansoni: an evaluation of existing methods and research towards single worm pair detection. Parasitology. 2018 09; 145(11):1355-1366. Ogongo P, Kariuki TM, Wilson RA. PMID: 29506583.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    27. Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model. Front Immunol. 2015; 6:273. Carvalho-Queiroz C, Nyakundi R, Ogongo P, Rikoi H, Egilmez NK, Farah IO, Kariuki TM, LoVerde PT. PMID: 26082781; PMCID: PMC4451692.
      View in: PubMed   Mentions: 9     Fields:    
    28. Identification and evaluation of Schistosoma mansoni proteins as diagnostic targets for schistosomiasis. International Journal of Infectious Diseases. 2014 Apr 1; 21:365. Ogongo OP. .
      View in: Publisher Site   Mentions:
    Paul's Networks
    Concepts (119)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (6)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.